Experience of hematopoietic stem cell transplantation (HSCT) in the patients infected with either hepatitis B or hepatitis C virus
Conclusions HSCT is a rugged job in Hbs-Ag positive or HCV-Ab positive patients due to more complications in the form of more neutropenia, GVHD, drug toxicity of chemotherapy, acute fulminant liver failure, fear of delaying of engraftment, and TRM. Careful evaluation before embarking on HSCT and intensive assessment against complications are warranted in Hbs-Ag positive and HCV-Ab positive recipients.
Source: Indian Journal of Transplantation - Category: Transplant Surgery Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Myeloid Leukaemia | Hepatitis | Hepatitis B | Hepatitis C | Hodgkin's Disease | Leukemia | Liver | Liver Transplant | Lymphoma | Myeloma | Skin | Skin Graft | Stem Cell Therapy | Stem Cells | Toxicology | Transplant Surgery | Transplants | Urology & Nephrology